These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 825707)
61. Recent advances in the treatment of viral hepatitis. Little JW Gen Dent; 2000; 48(6):672-9; quiz 680-1. PubMed ID: 12004662 [TBL] [Abstract][Full Text] [Related]
62. [Vertical hepatitis B transmission by anti-HBe positive hepatitis B carrier mothers]. Sacher M; Unger FD; Eder G Padiatr Padol; 1986; 21(2):141-6. PubMed ID: 3737217 [TBL] [Abstract][Full Text] [Related]
63. [Detection of Australia antigen (Au) in the serum of patients with infectious hepatitis]. Fekete B; Münnich D; Csinády G Orv Hetil; 1972 May; 113(19):1103-5. PubMed ID: 5023744 [No Abstract] [Full Text] [Related]
64. [Transmission of viruses (from A to E) and prevention]. Jouanolle H; Brissot P Rev Prat; 1990 Jun; 40(18):1660-6. PubMed ID: 2115202 [TBL] [Abstract][Full Text] [Related]
65. Technical aspects and results of the determination of hepatitis associated antigen (HAA) and antibody. Brummelhuis HG Vox Sang; 1970; 19(3):228-33. PubMed ID: 4993776 [No Abstract] [Full Text] [Related]
66. [Australia antigen: its practical significance in internal medicine]. Frei PC Schweiz Med Wochenschr; 1973 Aug; 103(33):1170-3. PubMed ID: 4751560 [No Abstract] [Full Text] [Related]
67. [Incidence of hepatitis virus infections and diseases in travelers returning from the tropics]. Holzer B; Weiss N; Stürchler D; Wall M Schweiz Med Wochenschr; 1980 Oct; 110(42):1514-21. PubMed ID: 7006071 [TBL] [Abstract][Full Text] [Related]
68. [The problem of hepatitis among mentally retarded patients]. Andrén-Sandberg M Lakartidningen; 1973 Dec; 70(51):4750-1. PubMed ID: 4793947 [No Abstract] [Full Text] [Related]
69. [Hepatitis A. I. Progress in the studies on the nature of the virus and the pathogenesis of the infection]. Krawczyński K Przegl Epidemiol; 1979; 33(3):397-407. PubMed ID: 228354 [No Abstract] [Full Text] [Related]
70. Hepatitis B antigen particles and prognosis in hepatitis. Popper H; Schaffner F N Engl J Med; 1973 Mar; 288(10):518-9. PubMed ID: 4684183 [No Abstract] [Full Text] [Related]
71. Vaccines for the decade of the 1980s and beyond. Hilleman MR S Afr Med J; 1982 May; 61(19):691-8. PubMed ID: 6281926 [TBL] [Abstract][Full Text] [Related]
74. [Prevention of transmission of hepatitis by HB antigen carriers]. Okada K Kango Gijutsu; 1979 Feb; 25(3):38-48. PubMed ID: 253776 [No Abstract] [Full Text] [Related]
75. Biophysical and biochemical properties of CR326 human hepatitis A virus. Provost PJ; Wolanski BS; Miller WJ; Ittensohn OL; McAleer WJ; Hilleman MR Am J Med Sci; 1975; 270(1):87-92. PubMed ID: 171955 [TBL] [Abstract][Full Text] [Related]
76. Superimposed hepatitis and the effect on viral replication in chronic hepatitis B. Rizzetto M; Ponzetto A; Bonino F; Purcell RH J Hepatol; 1986; 3 Suppl 2():S35-41. PubMed ID: 3298413 [No Abstract] [Full Text] [Related]
77. Development of vaccines against hepatitis A and hepatitis B. McLean AA Rev Infect Dis; 1986; 8(4):591-8. PubMed ID: 3018891 [TBL] [Abstract][Full Text] [Related]
78. [Recent findings on the field of viral hepatitis]. Deinhardt F; Frösner GG Internist (Berl); 1977 Apr; 18(4):188-94. PubMed ID: 194858 [No Abstract] [Full Text] [Related]